Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2021 Jun 21;101(10):1414. doi: 10.1038/s41374-021-00625-2

Correction to: A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer

Judith Martha Neumann 1, Karsten Niehaus 1, Nils Neumann 2, Hans Christoph Knobloch 3, Felix Bremmer 4, Ulrich Krafft 5, Udo Kellner 6, Peter Nyirády 7, Tibor Szarvas 5,7, Hanna Bednarz 1,8,, Henning Reis 9,
PMCID: PMC8440205  PMID: 34155317

Correction to: Laboratory Investigation 10.1038/s41374-021-00612-7, published online 21 May 2021

The original version of this article unfortunately contained a mistake. Due to the submission of Table 1 in a separate file, the following citations were missing in the references, leading to an incorrect linking in the table caption. The missing reference are:

(A) Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE. Malignant urachal lesions. J Urol. 131, 1–8 (1984).

(B) Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED, et al. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer. 107, 712–720 (2006).

(C) Brierley J, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. In: Brierley J, Gospodarowicz MK, Wittekind C, editors. Chichester, West Sussex, UK, Hoboken, NJ: John Wiley & Sons Inc; 2017.

The authors apologize for the mistake. The original article has been corrected.

Contributor Information

Hanna Bednarz, Email: hanna.bednarz@uni-bielefeld.de.

Henning Reis, Email: henning.reis@uk-essen.de.


Articles from Laboratory Investigation; a Journal of Technical Methods and Pathology are provided here courtesy of Nature Publishing Group

RESOURCES